Ventricular Cardiomyocytes

Human iPSC-derived Ventricular Cardiomyocytes

These cells are produced via standardized processes to possess a robust, ventricular-like phenotype. Their moderate spontaneous beat rate and well-defined action potentials make them particularly suitable for electrophysiological assays and compound profiling.

Benefits

Product Specifications

Feature

Detail

Identity Markers

≥ 85% cardiac Troponin T (cTnT+) by flow cytometry at Day 3; expression of ventricular marker MLC2v; sarcomeric markers (e.g. TNNT2), downregulation of progenitor/undifferentiated iPSC genes.

Quantities

≥ 1 × 10⁶ and ≥ 4 × 10⁶ viable cells

Quality Control

Cell count, viability, identity (FACS), functionality (e.g. Voltage Sensitive Dyes/Calcium Sensitive Probe: response to isoproterenol, dofetilide, nifedipine), mycoplasma testing

Format

Cryopreserved

Donor & Reprogramming

Specified donor (female/male; healthy/diseased as applicable); Sendai Virus reprogramming

Shipping / Storage

Dry shipper at -180°C to -135°C; store in vapor phase of liquid nitrogen

Supplied with

Cardiomyocyte culture medium; user-guide/instructions for thawing / seeding / maintenance / maturation

Figure 1. Electrophysiological validation. Greenstone Biosciences ventricular cardiomyocytes baseline action potentials and response to hERG Channel blockade ( red symbols, 30nM, E4031).

Technical Data

Explore Ventricular Cardiomyocytes

Discover our high-purity, iPSC-derived ventricular cardiomyocytes designed for cardiac safety, electrophysiology, and drug discovery research. Check out the product details to see how these cells can accelerate your studies.